Navigation Links
Alteon Initiates Phase 2 Trial of ALT-2074 in Diabetes and Haptoglobin 2-2

ity of patients to a defect in their cholesterol metabolism, which may promote atherosclerosis, and to a weakness in their antioxidant defense, so essential to the human body when oxygen is less available (during a heart attack for example).

Targeting a potent antioxidant drug candidate like ALT-2074 to these high risk patients is an example of targeted therapy. By redefining diabetes, Alteon believes that it can advance an efficient clinical development program in which a more appropriately targeted therapy is given to a more susceptible patient population.




'"/>




Page: 1 2

Related medicine news :

1. Bird Flu: Orissa Initiates Protective Measures
2. Biota Initiates Drug Testing War against Common Cold
3. Russia Initiates Mass Vaccination Of Poultry To Restrict Bird Flu
4. Government Initiates A Program To Curb HIV
5. Peregrine Pharmaceuticals Initiates Patient Enrollment In New Cotara(R) Brain Cancer Trial
6. SARS-Free Taiwan to Mark End Phase of Global Fight
7. Spray on contraceptive clears Phase I trial
8. Phase 3 trials of two multi-kinase inhibitors against cancer
9. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
10. Phase II trails of new HIV vaccine to be held in South Africa
11. FDA approves Phase 0 trial which tests experimental drugs on humans
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Alteon Initiates Phase Trial ALT Diabetes and Haptoglobin

(Date:9/30/2014)... ADOAMNI, Inc. reached its ... GoFundMe. The campaign, which surpassed its goal in 17 ... the funds necessary to convert a diesel powered bus ... School District (SUSD). The campaign rallied citizens of the ... the funds necessary for the conversion of a SUSD ...
(Date:9/30/2014)... 2014 More than 23 per cent of Canadians report ... stress increases the risk of poor mental and physical health, ... but for others especially those most likely to sweat ... , Thankfully, new research from Concordia University has found a ... huge help for healthcare professionals working to stop stress before ...
(Date:9/30/2014)... the University of Pittsburgh School of Dental Medicine have ... National Institute of Dental and Craniofacial Research, part of ... of the genetic roots of cleft lip and cleft ... in Colombia, Nigeria, the Philippines and Pennsylvania. , ... lip or palate that can form when a baby,s ...
(Date:9/30/2014)... Cold Spring Harbor Laboratory (CSHL) will perform research in ... announced in Washington today. The CSHL grants are among ... Health (NIH), totaling $46 million for the 2014-15 fiscal ... Initiative. , The Brain Research through ... in the spring of 2013. It seeks to revolutionize ...
(Date:9/30/2014)... Albany, New York (PRWEB) September 30, 2014 ... Research, a U.S.-based market intelligence agency states that the ... a value of USD 18.5 billion by the end ... was valued at USD 10.3 billion in 2012, will ... develop into a USD 18.5 billion worth market by ...
Breaking Medicine News(10 mins):Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 2Health News:ADOMANI Raises More Than 100,000 Dollars Through GoFundMe to Convert a School Bus 3Health News:How to predict who will suffer the most from stress 2Health News:Pitt team searches for genetic roots of cleft lip, palate 2Health News:4 Cold Spring Harbor Laboratory scientists will contribute to President Obama's BRAIN Initiative under new NIH grants 2Health News:4 Cold Spring Harbor Laboratory scientists will contribute to President Obama's BRAIN Initiative under new NIH grants 3Health News:Global Medical Imaging Reagents Market Segment up to 2019: Transparency Market Research 2Health News:Global Medical Imaging Reagents Market Segment up to 2019: Transparency Market Research 3
... chronically ill Medicaid patients designed to provide care ... Jan. 27 Chronically ill members ... Health Insurance plans (CHIP) in Philadelphia are now ... homes, thanks to an innovative new partnership with ...
... A study by healthcare market research firm Manhattan Research ... support for continuing medical education (CME) funding. The results ... in the medical community about the role of commercial ... positions of those who actually use continuing medical education, ...
... thinner, Munro & Associates steps up for their customersTROY, ... and great for our customers," says Sandy Munro, Founder ... deliver 21 years worth of experience more efficiently and ... in today,s climate could spell disaster. No company can ...
... in fruit flies has led researchers to a sensitive and ... common type of kidney cancer. In the journal Science ... the University of Chicago shows that the biomarker known as ... cell carcinomas but not by normal kidney tissue. , Physicians ...
... state, construct prison health care centers throughout California.LOS ANGELES, ... this week to prevent a federal judge and his ... treasury for the sole purpose of reconstructing the state,s ... opposes the proposal to construct seven new prison facilities, ...
... Ages Two Years and Older , FT. WASHINGTON, Pa., ... Inc., today announced the availability of Children,s ZYRTEC(R) Allergy ... flavor product used to treat perennial and seasonal allergic ... ages two years and older. Children,s ZYRTEC(R) Allergy ...
Cached Medicine News:Health News:Physician Home Visits Centerpiece of New AmeriChoice and INSPIRIS Partnership in Philadelphia 2Health News:Physician Home Visits Centerpiece of New AmeriChoice and INSPIRIS Partnership in Philadelphia 3Health News:Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education 2Health News:Manhattan Research Survey Finds That Physicians Overwhelmingly Support Commercially-Funded Continuing Medical Education 3Health News:Survival Favors the Prepared 2Health News:Roadkill study could speed detection of kidney cancer 2Health News:Ventura County Taxpayers' Group Files Suit to Stop State-of-the-Art Hospitals for Incarcerated Felons 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 2Health News:Children's Sugar-Free, Dye-Free ZYRTEC(R) Allergy Syrup Now Available 3
(Date:9/30/2014)... 30, 2014 Summary This report ... pharmaceutical companies regarding their Information & Communications Technology ... companies currently allocate their ICT budgets across the ... IT services, communications, and consulting. Key ... companies highlights that X% of respondents anticipate an ...
(Date:9/30/2014)... Investor-Edge has initiated coverage on the following ... Zentaris Inc. (NASDAQ: AEZS ), OPKO Health ... (NYSE MKT: NAVB), and Exact Sciences Corporation (NASDAQ: EXAS). ... at: http://investor-edge.com/register . On Monday, September ... 0.14%, the Dow Jones Industrial Average finished the day ...
(Date:9/30/2014)... 2014  Come fall, many children, teenagers, and even ... want to be for Halloween. And, a number of ... contact lenses bought without a prescription. Halloween, ... purchase and wear contact lenses without a prescription. According ... consumer survey, 17 percent of Americans have worn ...
Breaking Medicine Technology:ICT investment trends in pharmaceuticals - Enterprise ICT spending patterns through to the end of 2015 2ICT investment trends in pharmaceuticals - Enterprise ICT spending patterns through to the end of 2015 3Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 2Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 3Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 4Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences 5The Spooky Truth: What You Need To Know About Contact Lens Hygiene 2The Spooky Truth: What You Need To Know About Contact Lens Hygiene 3
... Quantros, a leading software and services provider for ... with Det Norske Veritas Healthcare, Inc. (DNV). DNV ... Medicare and Medicaid Services (CMS) as an authorized ... accreditation standards into the Quantros ACE(TM) software application. ...
... N.Y., Nov. 13 Misonix, Inc. (Nasdaq: MSON ... technology, which in Europe is used for the ablation ... has entered into a new, three year distribution agreement ... distribution of the SonaStar(TM) Ultrasonic Surgical Aspirator, the BoneScalpel(TM) ...
Cached Medicine Technology:Quantros Announces Partnership With Hospital Accreditation Agency DNV 2Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE) 2Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE) 3
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
... Quantitation of DNA, RNA, Or Fluorescent Tags. Accurate ... is critical to life science research. The RF-Mini ... measure quantities as small as 1ng/ml of DNA ... of excitation and emission filters, the RF-Mini 150 ...
The Fluoroskan Ascent FL is equipped with both fluorometric and luminometric measurement technologies, providing a full coverage for fluorometric, glow and flash luminometric applications even in the...
Medicine Products: